- About Immunology
- Graduate Program
- Postdoctoral Studies
- Seminars & Events
Dr. Phil Greenberg Named 2018 Leader in Health Care
Seattle Business Magazine honors cancer immunotherapy pioneer for his work on T-cell therapy.
Fred Hutchinson Cancer Research Center immunotherapy pioneer Dr. Phil Greenberg was honored last night with a Gold Award for Achievement in Medical Research at Seattle Business Magazine’s 2018 Leaders in Health Care Awards at Bell Harbor International Conference Center in Seattle. A panel of expert judges chose honorees in 10 categories based on their work to improve health care in the state.
Greenberg, head of the Hutch’s Program in Immunology, is developing new methods to train patients’ T cells to be effective and precise cancer killers. His work over the decades has been foundational for the development of the field. More than 40 of his former trainees now lead their own labs around the world, and several cell products developed in his lab have shown promise against different cancers in clinical trials.
“It’s really a very remarkable thing to realize that we can actually do this [T-cell therapy] now,” Dr. Phil Greenberg said in his acceptance speech for the Gold Award for Achievement in Medical Research. “We’ve always said in the laboratory that you should shoot for the moon, because even if you miss, you wind up among the stars.”
March 2, 2018 | By Susan Keown / Fred Hutch News Service
Photo courtesy of Seattle Business Magazine